Rating History for Mirati Therapeutics (MRTX) by Citi

More Stocks Rated by Citi | Latest Ratings for MRTX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/20/2023 Yigal Nochomovitz Downgrade Neutral
(Buy)		 59.00
(48.00)		 57.80
(58.70)		 1.56% Details